Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Noom offers cut-price compounded GLP-1 drug for obesity Digital health company Noom has launched a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide to make the drug more accessible to consumers in the US
Why some people experience mood changes On the other hand, some users report increased anxiety, irritability, or low mood during GLP1 treatment
Symptoms typically peak during the first 48 weeks or after dose increases, then often improve as the body adapts
These side effects usually go away on their own within a few weeks
US$ 22.55
US$ 23.05
US$ 29.58
US$ 28.86
US$ 20.77
US$ 23.24
